（ 研究業績 ） output

すべて 論文

  • 27. Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma.

    Nakamura T, Miyabe H, Hyodo M, Sato Y, Hayakawa Y, Harashima H*.
    J Control Release 216: 149-157 (2015).

    DOI : 10.1016/j.jconrel.2015.08.026.

    論文

  • 26. The intracellular pharmacodynamics of siRNA is responsible for the low gene silencing activity of siRNA-loaded nanoparticles in dendritic cells.

    Nakamura T, Fujiwara Y, Warashina S, Harashima H*.
    Int J Pharm 494: 271-277 (2015).

    DOI : 10.1016/j.ijpharm.2015.08.009.

    論文

  • 25. Influence of endosomal escape and degradation of α-galactosylceramide loaded liposomes on CD1d antigen presentation.

    Nakamura T, Kuroi M, Harashima H*.
    Mol Pharm 12: 2791-2799 (2015).

    DOI : 10.1021/mp500704e.

    論文

  • 24. A KALA-modified lipid nanoparticle containing CpG-free plasmid DNA as a potential DNA vaccine carrier for antigen presentation and as an immune-stimulative adjuvant.

    Miura N, Shaheen SM, Akita H*, Nakamura T, Harashima H.
    Nucleic Acids Res 43: 1317-1331 (2015).

    DOI : 10.1093/nar/gkv008.

    論文

  • 23. Mechanism responsible for the antitumor effect of BCG-CWS using the LEEL method in a mouse bladder cancer model.

    Nakamura T, Fukiage M, Suzuki Y, Yano I, Miyazaki J, Nishiyama H, Akaza H, Harashima H*.
    J Control Release 196: 161-167 (2014).

    DOI : 10.1016/j.jconrel.2014.10.007.

    論文

  • 22. Octaarginine-modified liposomes enhance cross-presentation by promoting the C-terminal trimming of antigen peptide.

    Nakamura T, Ono K, Suzuki Y, Moriguchi R, Kogure K, Harashima H*.
    Mol Pharm 11: 2787-2795 (2014).

    DOI : 10.1021/mp500147y.

    論文

  • 21. A new adjuvant delivery system ‘cyclic di-GMP/YSK05 liposome’ for cancer immunotherapy.

    Miyabe H, Hyodo M, Nakamura T, Sato Y, Hayakawa Y, Harashima H*.
    J Control Release 184: 20-27 (2014).

    DOI : 10.1016/j.jconrel.2014.04.004.

    論文

  • 20. Glycerol monomycolate is a novel ligand for the human, but not mouse macrophage inducible C-type lectin, mincle.

    Hattori Y, Morita D, Fujiwara N, Mori D, Nakamura T, Harashima H, Yamasaki S*, Sugita M*.
    J Biol Chem 289: 15405-15412 (2014).

    DOI : 10.1074/jbc.M114.566489.

    論文

  • 19. Nanoparticulation of BCG-CWS for application to bladder cancer therapy.

    Nakamura T, Fukiage M, Higuchi M, Nakaya A, Yano I, Miyazaki J, Nishiyama H, Akaza H, Ito T, Hosokawa H, Nakayama T, Harashima H*.
    J Control Release 176: 44-53 (2014).

    DOI : 10.1016/j.jconrel.2013.12.027.

    論文

  • 18. Th1-skewed tissue responses to a mycolyl glycolipid in mycobacteria-infected rhesus macaques.

    Morita D, Miyamoto A, Hattori Y, Komori T, Nakamura T, Igarashi T, Harashima H, Sugita M*.
    Biochem Biophys Res Commun 441: 108-113 (2013).

    DOI : 10.1016/j.bbrc.2013.10.021.

    論文